Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Contrast agents includes computed tomography (CT) contrast agents, magnetic resonance imaging (MRI) contrast agents and ultrasound contrast agents (microbubbles). GlobalData uses proprietary data and analytics to provide a comprehensive report on the contrast agents market in Chile. Buy the latest report here.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Computed tomography (CT) is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with high risk of heart disease. It can also be used to image complex fractures, detect infarction, tumors, calcifications, hemorrhage and bone trauma and also acute and chronic changes in the lung parenchyma. This segment includes ionic iodinated CT contrast agents, non-ionic iodinated CT contrast agents and barium CT contrast agents.
The contrast agents market in Chile can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size contrast agents in Chile, buy the report here.